Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

Diabetes, Obesity & Metabolism
Philip HomeM Massi-Benedetti

Abstract

To estimate absolute and relative incidence rates of hypoglycaemia when using once-daily evening or morning regimens of insulin glargine (glargine) versus once-daily evening NPH insulin (NPH) using individual patient data (IPD). Randomized controlled trials with accessible IPD and including white European people with type 2 diabetes (T2DM) using glargine or NPH once-daily (with oral glucose-lowering drugs) were identified. Two study pools were analysed: evening glargine versus evening NPH (pool 1); and morning glargine versus evening NPH (pool 2). The number-needed-to-treat to avoid hypoglycaemia was calculated for glargine versus NPH. In study pool 1 (n = 2711), the risk of nocturnal hypoglycaemia was approximately halved with glargine compared with NPH [odds ratios (OR): 0.44-0.52, p < 0.001-0.047]. This led to a significant reduction in anytime risk of symptomatic hypoglycaemia [plasma glucose (PG) <3.9 mmol/l, OR: 0.64, p = 0.018; PG <2.0 mmol/l, OR: 0.51, p < 0.001]. In study pool 2 (n = 470), although a strong numerical reduction in all types of nocturnal hypoglycaemia was observed (OR: 0.16-0.64), statistical significance was reached only for symptomatic hypoglycaemia with PG <3.9 mmol/l (p < 0.001). Eight (pool 1) or fi...Continue Reading

Associated Clinical Trials

References

Sep 1, 1987·Diabetes Care·D J CoxJ Butterfield
Feb 18, 1995·BMJ : British Medical Journal·R J Cook, D L Sackett
Jun 6, 1998·The New England Journal of Medicine·T W JonesW V Tamborlane
Apr 17, 2001·Annals of Internal Medicine·D MoherUNKNOWN CONSORT GROUP (Consolidated Standards of Reporting Trials)
Apr 17, 2001·Annals of Internal Medicine·D G AltmanUNKNOWN CONSORT GROUP (Consolidated Standards of Reporting Trials)
Sep 12, 2001·Lancet·D R OwensG B Bolli
Sep 28, 2001·Journal of the American Podiatric Medical Association·D MoherUNKNOWN CONSORT Group (Consolidated Standards of Reporting Trials)
Jan 29, 2002·Statistics in Medicine·Jesse A BerlinUNKNOWN Anti-Lymphocyte Antibody Induction Therapy Study Group
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
May 8, 2003·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M Massi BenedettiM Ziemen
Jun 18, 2003·Spine·Maurits van TulderUNKNOWN Editorial Board of the Cochrane Collaboration Back Review Group
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Oct 28, 2003·Diabetes Care·Matthew C RiddleUNKNOWN Insulin Glargine 4002 Study Investigators
May 1, 2004·Cleveland Clinic Journal of Medicine·Ilan Gabriely, Harry Shamoon
May 26, 2004·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Mar 12, 2005·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Jonas LundkvistLinus Jönsson
May 14, 2005·Journal of Occupational and Environmental Medicine·George G RhoadsQuanwu Zhang
Oct 4, 2005·Current Medical Research and Opinion·Ruth E DavisCraig J Currie
May 24, 2006·Archives of Medical Research·Freddy G EliaschewitzUNKNOWN HOE 901/4013 LA Study Group
Oct 3, 2006·Diabetes Research and Clinical Practice·Chang-Yu PanUNKNOWN LEAD Study Investigators Group
Apr 4, 2007·The Journal of Clinical Investigation·Philip E Cryer
Jun 20, 2007·Clinical Therapeutics·Donald R MillerBenjamin G Fincke
Dec 7, 2007·Best Practice & Research. Clinical Endocrinology & Metabolism·Julia M Bottomley, Frank D Raymond
Dec 20, 2007·Diabetes/metabolism Research and Reviews·Brian M Frier
Jan 25, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·S A AmielK Jameson
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Dec 6, 2008·Diabetes Research and Clinical Practice·Simon R Heller

❮ Previous
Next ❯

Citations

Jan 9, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Jason GordonJiten Vora
Jun 28, 2011·Diabetes Technology & Therapeutics·Stuart LittlePhilip Home
Jun 28, 2011·Diabetes Technology & Therapeutics·Maka S HedringtonStephen N Davis
Aug 26, 2011·Diabetes Technology & Therapeutics·Geremia B BolliEllie S Strock
Nov 14, 2012·Therapeutic Advances in Endocrinology and Metabolism·Dario Giugliano, Katherine Esposito
Dec 14, 2011·Journal of Endocrinological Investigation·F FeboP M Piatti
Dec 5, 2012·ISRN Endocrinology·Edoardo Mannucci
May 16, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Björn EliassonAnn-Marie Svensson
Apr 8, 2014·Revista clínica española·M Cano Megias, P Guisado Vasco
Jan 5, 2012·Expert Opinion on Biological Therapy·Katherine Esposito, Dario Giugliano
Aug 27, 2011·Current Medical Research and Opinion·Scott E Nelson
Jan 6, 2016·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberUNKNOWN American College of Endocrinology (ACE)
Jun 16, 2015·Revista española de geriatría y gerontología·Francesc FormigaLeocadio Rodríguez Mañas
Feb 9, 2013·Endocrinology and Metabolism Clinics of North America·Candace M RenoSimon J Fisher
Dec 4, 2012·Medicina clínica·Ricardo Gómez HuelgasUNKNOWN en nombre del Grupo de Trabajo para el Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el anciano
May 12, 2012·Endocrinology and Metabolism Clinics of North America·Jack L Leahy
Dec 8, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberUNKNOWN American College of Endocrinology (ACE)
Jun 21, 2015·Contemporary Clinical Trials·Mark SimmondsLesley Stewart
Mar 2, 2013·Diabetes, Obesity & Metabolism·G Grunberger
Sep 13, 2013·Diabetes/metabolism Research and Reviews·David R OwensLouis Monnier
Oct 4, 2011·Diabetes Research and Clinical Practice·G C HallP D Home
May 9, 2015·European Journal of Internal Medicine·José Miguel Seguí RipollJaime Merino Sánchez
Oct 6, 2014·The American Journal of Medicine·Steven Edelman, Jeremy Pettus
Apr 15, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Yehuda HandelsmanFarhad Zangeneh
Jul 24, 2013·Neurochemistry International·Gabriela LangurenLourdes Massieu
Oct 27, 2011·Yonsei Medical Journal·Shih-Hung TsaiDer-Ming Chu
Oct 29, 2015·Diabetes/metabolism Research and Reviews·Jeremy PettusSteven Edelman
Aug 1, 2015·The International Journal of Psycho-analysis·Yoram YovellAikaterini Fotopoulou
Jan 18, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberGuillermo E Umpierrez
Jun 14, 2013·Journal of Diabetes Science and Technology·Sabine ArnoldsJochen Sieber
Jun 27, 2017·Journal of Medical Economics·Unchalee PermsuwanNathorn Chaiyakunapruk
Jan 26, 2018·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberGuillermo E Umpierrez
Feb 12, 2019·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberGuillermo E Umpierrez
Mar 28, 2019·Journal of Diabetes·Zachary Bloomgarden, Guang Ning
Jul 12, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Philip A LevinLee A Bromberger
Oct 1, 2019·American Journal of Therapeutics·Pablo Aschner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.